February 12, 2025: Levee Medical®, a medical device company developing innovative solutions for prostate cancer surgery patients, has successfully closed its Series B financing round, securing over $14 million, including note conversions2. This significant funding will accelerate the development of their Voro® Urologic Scaffold, an absorbable device designed to reduce post-prostatectomy urinary incontinence2.

The company has made substantial progress in its ARID feasibility study, which is evaluating the safety and performance of the Voro Urologic Scaffold. Notably, Dr. Gustavo Espino, Principal Investigator at Hospital Nacional in Panama City, has successfully enrolled 28 patients in the study2. This achievement underscores the growing importance of Latin America as a hub for medical device clinical trials.

Dr. Espino commented on the promising results: "Our experience with the Voro Urologic Scaffold has been highly encouraging. The device had an outstanding safety profile, and patients have noted early improvements in continence, which translates to a considerably better quality of life post-surgery"2.

As the leading Medtech contract research organization (CRO) in Latin America, bioaccess® is proud to highlight the success of innovative companies like Levee Medical in conducting clinical studies in the region. bioaccess® stands out as the only Medtech CRO in Latin America specializing in helping Medtech startups conduct their first-in-human studies in Panama and throughout Latin America.

The Voro Urologic Scaffold, designed to be placed during prostatectomy procedures, aims to manage the geometry of the bladder neck and maintain urethral length, which are critical factors in preventing post-operative incontinence2. This innovative approach could potentially revolutionize outcomes for prostate cancer surgery patients.

Adam Irving, CEO of Levee Medical, expressed gratitude for the support: "There is substantial interest in our efforts to help men get drier sooner after surgery. We are deeply grateful for the incredible support we've received in bringing transformative solutions to patients and providers"2.

The success of Levee Medical's clinical studies in Panama further emphasizes Latin America's potential as a prime destination for medical device clinical trials. With its expertise and regional focus, bioaccess® continues to play a crucial role in facilitating groundbreaking medical research and development in Latin America.